Public Policy and Relations Committee

Most professional societies invest in educating the public and public policy makers.  The investment is often a large percentage of the society’s operating budget if its members derive a significant portion of their business or personal income from the government.  The U.S. Federal government purchases more than half of all clinical care and is the most important source of research support through a host of agencies including the NIH, DoD, VA, CDC, CMS, and AHRQ.  The majority of ANA members received a significant portion of their income for research and clinical practice from the government and the ANA must, therefore, invest significantly in a well- developed and coordinated public policy effort that fully aligns with the Association’s mission of advancing academic neurology and the neurologic sciences. Members also provide representation on the AAN’s Ethics, Law and Humanities Committee. 

Need support for your Advocacy Effort?
Send your request to to be put forth to the Public Policy and Relations Committee 



Barbara S. Giesser, MD
2018 - 2020
University of California, Los Angeles



Seemant Chaturvedi, MD
2016 - 2019
University of Miami                        

Elias A. Giraldo, MD, MS
2017 - 2020
California University of Science and Medicine

Luigi Maccotta, MD, PhD
2016 - 2019
Washington University in St. Louis   


John  Ravits, MD
2018 - 2020
University of California, San Diego

Lesli Skolarus, MD, MS
2016 - 2019
University of Michigan

Clifton L. Gooch, MD
2016 - 2020
University of South Florida
Board Liaison

Mathew Rizzo, MD
2018 - 2021
University of Nebraska Medical Center